Veeva adds to Vault regulatory capabilities for medical devices, diagnostics

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Denis Isakov)
(Image: Getty/Denis Isakov)

Related tags: Veeva Systems

Veeva Systems has boosted its capabilities in its Veeva Vault RIM to manage regulatory documents and processes for medical devices and diagnostics manufacturers.

According to the company, the expansion will enable organizations to unify product registrations, health authority correspondence and commitments, as well as submissions documents on a single cloud platform.

Medical device product registration data is modeled to conform with US and EU Unique Device Identification (UDI) guidelines and supports submissions formats such as Summary Technical Documentation (STED), International Medical Device Regulators Forum (IMDRF​), and 510(k)​.

The medical device and diagnostics market is expected to reach $409bn by 2023, increasing at a growth rate of 4.5%, explained Terri Howard, director of medical device and diagnostics strategy for Veeva Systems.

“The increasing geriatric population and focus on personalized medicines to treat chronic diseases such as cardiovascular and renal disease are two major drivers for the growth of new and advanced forms of diagnostic testing – and are contributing to the need for better technology in this industry,” ​she told us.

This, paired with increased regulatory burden, financial pressures, and market access challenges, Howard said there is an “urgent needfor device and diagnostics companies to increase agility and get their innovations to market fast.

“Prevailing technology no longer cuts it as many manufacturers are still using multiple share point sites and Excel spreadsheets to manage and track submissions ⁠— which sufficed a decade ago but market forces and the regulatory landscape are dramatically different today,” ​said Howard.

“These manual processes and disparate systems limit visibility and make it difficult to ensure consistency across the end-to-end regulatory process,”​ she added. “It causes delay at every step and ultimately, slows innovative products from reaching patients.

Earlier this month, Veeva announced Vault Safety.AI​, which will be integrated to its cloud-based suite, available in April 2020.

Safety.AI automatically converts text input from sources including social media, fax, email, literature, and call center notes and fills the required fields in a drug safety case, according to the company.

Related news

Show more

Related products

show more

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars